Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
Clinical trial NCT05360446 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05360446
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2026-10-26
- Enrollment
- 609
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.